TELA Bio (TELA) Tax Provisions (2025 - 2026)
TELA Bio's (TELA) quarterly Tax Provisions came in at $60000.0 in Q1 2026, up 15.38% year-on-year from $52000.0 in Q1 2025, and up 5900.0% quarter-over-quarter from $1000.0 in Q4 2025.
TELA Bio (TELA) Tax Provisions (2025 - 2026) Analysis & Trends
TELA Bio's Tax Provisions history runs 2 years deep, the most recent figure standing at $60000.0 for Q1 2026.
- On a quarterly basis, Tax Provisions rose 15.38% year-over-year to $60000.0 in Q1 2026; TTM through Mar 2026 was $94000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $86000.0, up 101.08% from the prior year.
- Tax Provisions rose to $60000.0 in Q1 2026 per TELA's latest filing, from $1000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $60000.0 in Q1 2026 and bottomed at $1000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 372.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 105.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 575.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -176.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 70.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -51.51 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 94.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TELA Bio | 40.65 Mn | 1.11 Mn | 12.52 Mn | 60,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Jun 30, 2025 | 33,000.00 |
| Mar 31, 2025 | 52,000.00 |